Get started
Reviva Pharmaceuticals Holdings, Inc.Reviva Pharmaceuticals Holdings, Inc.Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Minds

RVPHW chart

Key stats

Market capitalization
‪37.27 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.5927USD
Net income (FY)
‪−39.26 M‬USD
Revenue (FY)
—
Shares float
‪24.87 M‬
Beta (1Y)
−0.48

About Reviva Pharmaceuticals Holdings, Inc.

Sector
Health Technology
CEO
Laxminarayan Bhat
Headquarters
Cupertino
Website
revivapharma.com
Employees (FY)
15
Founded
2020
FIGI
BBG00M8LPQW6
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.